TREATMENTS OF RADIOIODINE- REFRACTORY DIFFERENTIATED THYROID CANCER IN ROUTINE CLINICAL PRACTICE - A SYSTEMATIC REVIEW

被引：0
|
作者：
Bhutani, M. K. [1 ]
Rajora, P. [1 ]
Soni, D. [1 ]
Pan, J. J. [2 ]
机构：
[1] BresMed Hlth Solut India Pvt Ltd, Gurugram, India
[2] Eisai Inc, Woodcliff Lake, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.088
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN5
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [1] Clinical guidance for radioiodine refractory differentiated thyroid cancer
    Gild, Matti L.
    Topliss, Duncan J.
    Learoyd, Diana
    Parnis, Francis
    Tie, Jeanne
    Hughes, Brett
    Walsh, John P.
    McLeod, Donald S. A.
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 88 (04) : 529 - 537
  • [2] Radioiodine refractory differentiated thyroid cancer
    Jin, Yuchen
    Van Nostrand, Douglas
    Cheng, Lingxiao
    Liu, Min
    Chen, Libo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 111 - 120
  • [3] Radioiodine refractory differentiated thyroid cancer
    Boudina, Maria
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 65 - 68
  • [4] Clinical and molecular profiles of radioiodine refractory differentiated thyroid cancer
    Lin, Y.
    Zhang, X.
    He, H.
    Huang, L.
    Ding, S.
    Kai, Z.
    Lin, R.
    Luo, P.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1300 - S1300
  • [5] Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine- refractory differentiated thyroid cancer
    Tahara, Makoto
    Brose, Marcia S.
    Wirth, Lori J.
    Suzuki, Takuya
    Miyagishi, Hideaki
    Fujino, Katsuki
    Dutcus, Corina E.
    Gianoukakis, Andrew
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 106 : 61 - 68
  • [6] Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer
    Weitzman, Steven P.
    Sherman, Steven, I
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 253 - +
  • [7] Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta-analysis
    Yu, Jiayi
    Liu, Zheran
    Su, Yonglin
    Peng, Xingchen
    Xie, Yuping
    [J]. CLINICAL ENDOCRINOLOGY, 2024, 100 (04) : 379 - 388
  • [8] Advanced Radioiodine-refractory differentiated Thyroid Cancer
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Geisler, Julia
    Boeck, Stefan
    Heinemann, Volker
    Bartenstein, Peter
    Goeke, Burkhard
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (03) : 168 - 171
  • [9] Treatment strategy by radioiodine refractory differentiated thyroid cancer
    Mantsopoulos, Konstantinos
    Mueller, Sarina K.
    Pavel, Marianne
    Kuwert, Torsten
    Meidenbauer, Norbert
    Fietkau, Rainer
    Sievert, Matti
    Iro, Heinrich
    [J]. LARYNGO-RHINO-OTOLOGIE, 2022, 101 (04) : 298 - 303
  • [10] Cabozantinib for radioiodine-refractory differentiated thyroid cancer
    Chiapponi, Costanza
    Hartmann, Milan J. M.
    Hescheler, Daniel A.
    Alakus, Hakan
    [J]. ONKOLOGE, 2021, 27 (12): : 1241 - 1242
12345